Amgen Boasts Success In Sjogren's; Shares Charge Ahead

Amgen stock bounded above its 50-day line Tuesday after publishing promising results for its experimental Sjogren's treatment. The post Amgen Boasts Success In Sjogren's; Shares Charge Ahead appeared first on Investor's Business Daily.